Press release
Artificial Intelligence in Cancer Diagnosis and Therapy Market Report- Expansive Coverage on the Profit Sources
According to the latest research by InsightAce Analytic, the global Artificial Intelligence in Cancer Diagnosis and Therapy market is valued at US$ 548.11 Million in 2021, and it is expected to reach US$ 5.62 Billion by 2030, with a CAGR of 30.1% during a forecast period of 2022-2030.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/1294
Cancer is a disease caused by abnormal cell development. It is one of the significant causes of death in the world. Early detection and treatment of cancer can enhance survival rates. Artificial intelligence (AI) is a subfield of computer science concerned with simulating intelligent behaviour in computers. Cancer is diagnosed and treated using AI techniques. AI-powered systems can detect patterns in data that humans cannot see. These techniques can also be used to forecast the development and progression of cancer. AI is being applied in the detection and treatment of cancer. AI-based systems can detect subtle irregularities in photos that humans cannot detect. AI is also being utilized to create new medications and individualized cancer cures.
One of the main drivers propelling the growth of this market is the increase in demand for precision medicine and early cancer detection, as well as the emergence of very sophisticated AI systems. Cancer is one of the significant causes of mortality worldwide. According to the same source, low- and middle-income nations account for roughly 70% of all cancer-related fatalities.
Therefore, one of the key reasons anticipated to propel this market's growth over the forecast period is the rising incidence of cancer. The development of multidisciplinary platforms and advancements in prognosis accuracy using cutting-edge AI and Machine Learning (ML) methods have increased the accuracy of cancer susceptibility, recurrence, and cancer prediction. These factors are the main drivers of AI in cancer diagnosis and therapy market revenue growth.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1294
North America is anticipated to be the major contributor to the Artificial Intelligence in Cancer Diagnosis and Therapy market over the forecast years. This region's substantial share can be attributable to the presence of essential market players and the rising prevalence of cancer. According to the American Cancer Society, around 1,762,450 new cancer cases are predicted to be diagnosed in 2019, with 606,880 individuals dying from cancer in the United States. To combat this issue, the region is actively deploying AI. Cancer tumour profiling has significantly increased clinical and research uses in this region. In addition, the Asia Pacific Artificial Intelligence in Cancer Diagnosis and Therapy market is expected to grow considerably during the forecast period because of increased investment in AI healthcare startups, more significant usage of AI in sickness diagnosis, and its ability to provide numerous areas of patient care.
Major market players operating in the Artificial Intelligence in Cancer Diagnosis and Therapy market include
Pfizer Inc., Therapixel, Sophia Genetics, Janssen Global Services, LLC., PathAI, IBM, Microsoft, Oracle, OncoHealth, and Ancora Medical.
Recent collaborations and agreements in the market:
• In September 2021, The Center for Devices and Radiological Health of the Digital Health Center of Excellence released the Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. The FDA's Center for Devices and Radiological Health (CDRH) recommends comprehensive regulations for these technologies based on the entire product lifecycle. These regulations will allow modifications based on learning and adaptation from real-world experience while maintaining the safety and efficacy of software as a medical device.
• In January 2021, A cooperation agreement for the AI-driven clinical interpretation platform ClinOme was struck by 4baseCare, a Precision Oncology startup backed by Illumina Accelerator and the Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC) - Tata Memorial Centre. Through this collaboration, it will be possible for clinicians to offer patients with cancer-tailored treatment plans by developing a native platform that delivers data insights and streamlined reports.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1294
Market Segments
Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Surgery Type, 2022-2030 (Value US$ Mn)
• Radiotherapy
• Chemotherapy
• Immunotherapy
• Precision Therapy
• Phototherapy
• Gene Therapy
• Sonodynamic Therapy
Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Cancer Type, 2022-2030 (Value US$ Mn)
• Breast Cancer
• Lung Cancer
• Melanoma Cancer
• Colorectal Cancer
• Prostate Cancer
• Others
Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by End-Use, 2022-2030 (Value US$ Mn)
• Hospitals
• Cancer Research Center
• Diagnostic Labs
Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Artificial Intelligence in Cancer Diagnosis and Therapy market
To receive an industry overview and future trends of the Artificial Intelligence in Cancer Diagnosis and Therapy market
To analyze the Artificial Intelligence in Cancer Diagnosis and Therapy market drivers and challenges
To get information on the Artificial Intelligence in Cancer Diagnosis and Therapy market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Artificial Intelligence in Cancer Diagnosis and Therapy market industry
Get more information: @
https://www.insightaceanalytic.com/report/global-artificial-intelligence-in-cancer-diagnosis-and-therapy-market/1294
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence in Cancer Diagnosis and Therapy Market Report- Expansive Coverage on the Profit Sources here
News-ID: 3807545 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Prochlorperazine Maleate Market Size, Share and Trends Analysis Report 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Prochlorperazine Maleate Market- (By Indication (Nausea and Vomiting Management, Vertigo, Mental Health Disorders (e.g., Schizophrenia)), By Dosage Form (Oral Tablets, Rectal Suppositories, Injectable Formulations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research…
Primary Cells Market Survey Detailed Analysis and Forecast 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Primary Cells Market- (By Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Life Science Research Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Primary Cells Market Size is valued at USD…
Predictive Disease Analytics Market expected to Witness Huge Revenue Growth to 2 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Predictive Disease Analytics Market Size, Share & Trends Analysis Report By Component (Hardware, Software & Services), By Deployment (On-premise and Cloud-based), By End-user (Healthcare Providers, Healthcare Payers)- Market Outlook And Industry Analysis 2034"
The Global Predictive Disease Analytics Market is estimated to reach over USD 22.6 Bn by 2034, exhibiting a CAGR of 21.2% during…
Predictive Biomarkers Market Current Scenario with Future Trends Analysis to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Predictive Biomarkers Market- (By Indication (Cancer, Neurological Disorder, Cardiovascular Disorder, Immunological Disorder, Others), By End-Use (Diagnostic Centers, Contract Research Organizations (CROs), Academic Research Institutes, Pharma & Biotech Companies, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Predictive Biomarkers Market is expected to grow with…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
